Novavax (NVAX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $3.95 --0%
EPS Growth %: +72.1%
Financial Fact:
Interest income: 554K
Today's EPS Names:
WF, CWBC, GLTO, More
EPS Growth %: +72.1%
Financial Fact:
Interest income: 554K
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $14 million versus the consensus estimate of $9.9 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Ball Corporation (BALL) Tops Q1 EPS by 12c
- Amundi surges as on bigger-than-expected profit, record AUM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
